Articles Found

Page: 1 2 3 4 5 6 7 8 9 10 ... Next »

Recent Articles   Industry   Published  Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan Pharma / BioTech / Nutrition 2026/03/26 More Locus FS Receives the 2026 North American Precision Fermentation Technology Innovation Leadership Recognition Pharma / BioTech / Nutrition 2026/03/25 More Ipsen Showcases Transformative Potential of Early Immuno-oncology Pipeline At AACR Pharma / BioTech / Nutrition 2026/03/18 More Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology Pharma / BioTech / Nutrition 2026/03/03 More Ono Pharma Announces Transfer of the Manufacturing and Marketing Approval Authorization for Opalmon® Tablets and Prostandin® Ointment Pharma / BioTech / Nutrition 2026/03/02 More Ono Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory Pharma / BioTech / Nutrition 2026/02/16 More SCHOTT Pharma Launches EVERIC® Lyo & Amber Vials for Light-sensitive ADCs Pharma / BioTech / Nutrition 2026/01/22 More Arbitration Tribunal Upholds Ipsen’s Termination of R&D Agreement with Galderma Pharma / BioTech / Nutrition 2026/01/21 More New Data Reinforces Ipsen’s Commitment to Bringing Solutions and Addressing Care Gaps in Neurological Diseases At TOXINS Pharma / BioTech / Nutrition 2026/01/15 More Opdivo® Intravenous Infusion Approved in Taiwan in Combination with Yervoy® for the Treatment of Adult Patients Pharma / BioTech / Nutrition 2026/01/14 More U.S. FDA Grants Ipsen’s IPN60340 (ICT01) Breakthrough Therapy Designation in First Line Unfit Acute Myeloid Leukemia Pharma / BioTech / Nutrition 2026/01/13 More Additional Approval of Combination Therapy with BRAFTOVI® Capsule, a BRAF Inhibitor, for the Indication of Colorectal Cancer in South Korea Pharma / BioTech / Nutrition 2026/01/13 More BostonGene Recognized by Frost & Sullivan for 2025 Global Technology Innovation Leadership in AI-Driven Precision Oncology Solutions Pharma / BioTech / Nutrition 2026/01/12 More Ipsen Expands Early Development Pipeline with Simcere Zaiming’s Innovative Antibody Drug Conjugate Pharma / BioTech / Nutrition 2025/12/22 More Ipsen Update on Phase II FALKON Trial in Patients with Ultra-rare Bone Disease, Fibrodysplasia Ossificans Progressiva (FOP) Pharma / BioTech / Nutrition 2025/12/19 More

---

Page: 1 2 3 4 5 6 7 8 9 10 ... Next »